Biocon Ltd. — Investor Relations & Filings
Biocon Ltd. is a global biopharmaceutical company focused on developing innovative therapies for chronic conditions such as diabetes, oncology, and autoimmune diseases. The company specializes in the research, development, and manufacture of high-quality biosimilars, generic active pharmaceutical ingredients (APIs), and novel biologics. Its portfolio includes recombinant human insulin, insulin analogs, and monoclonal antibodies. Biocon leverages an integrated business model encompassing advanced research and development, large-scale manufacturing, and global commercialization. By prioritizing affordable innovation, the company aims to enhance access to life-saving treatments across international markets, including the United States, Europe, and emerging economies. Its technical expertise in microbial fermentation and complex protein engineering supports a robust pipeline of complex therapeutics designed to address unmet medical needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Investor Presentation | 2026-05-08 | English | |
| Monitoring Agency Report | 2026-05-07 | English | |
| Record Date | 2026-05-07 | English | |
| Press Release | 2026-05-07 | English | |
| Outcome of Board Meeting | 2026-05-07 | English | |
| Outcome of Board Meeting | 2026-05-07 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 43955963 | Investor Presentation | 2026-05-08 | English | ||
| 43390572 | Monitoring Agency Report | 2026-05-07 | English | ||
| 43348518 | Record Date | 2026-05-07 | English | ||
| 43348530 | Press Release | 2026-05-07 | English | ||
| 43348544 | Outcome of Board Meeting | 2026-05-07 | English | ||
| 43348559 | Outcome of Board Meeting | 2026-05-07 | English | ||
| 43348574 | Outcome of Board Meeting | 2026-05-07 | English | ||
| 43348589 | Change in Auditors | 2026-05-07 | English | ||
| 43348605 | Dividend | 2026-05-07 | English | ||
| 43348619 | Outcome of Board Meeting | 2026-05-07 | English | ||
| 42162648 | News Verification | 2026-05-06 | English | ||
| 42162683 | Rumour Verification - Regulation 30(11) | 2026-05-06 | English | ||
| 42271037 | Board Meeting — Board Meeting Intimation | 2026-05-04 | English | ||
| 42271069 | Board Meeting — Fund Raising | 2026-05-04 | English | ||
| 42181205 | Updates | 2026-04-30 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Avivagen Inc.
Developed natural health products and feed additives; filed…
|
VIV | CA | Manufacturing |
|
Awakn Life Sciences Corp. (1169082 BC Ltd.)
Clinical-stage biotech developing novel therapeutics, inclu…
|
AWKN | CA | Manufacturing |
|
Axcan Pharma Inc.
Specialty pharmaceutical company focused on prescription th…
|
AXCA | CA | Manufacturing |
|
Axogen, Inc.
Develops and commercializes surgical solutions for peripher…
|
AXGN | US | Manufacturing |
|
Axsome Therapeutics, Inc.
A biopharmaceutical company developing therapies for centra…
|
AXSM | US | Manufacturing |
|
AYTU BIOPHARMA, INC
A specialty pharma company developing novel therapeutics fo…
|
AYTU | US | Manufacturing |
|
Ayurcann
Award-winning post-harvest cannabis solution provider offer…
|
AYUR | CA | Manufacturing |
|
Azitra, Inc.
Clinical-stage biopharma company developing microbiome-base…
|
AZTR | US | Manufacturing |
|
Bachem Holding AG
A CDMO developing and manufacturing peptides and oligonucle…
|
BANB | CH | Manufacturing |
|
Bacil Pharma Ltd.
Manufactures generic pharmaceutical formulations across var…
|
524516 | IN | Manufacturing |
Biocon Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/61176/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=61176 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=61176 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=61176 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 61176}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Biocon Ltd. (id: 61176)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.